Pressure Sore
15
2
2
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (15)
Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.
NPWTi on Closure of Chronic Pressure Sores
Kinesiophobia and Pressure Sore Risk After Bariatric Surgery.
Treatment of Pressure Ulcers Using Biological Skin Substitutes
Evaluation of the Impact of a Digital Tool MEDIASCREEN of Preventive Information for Patients on the Knowledge of the Risk of Pressure Sores Acquired During a Hospitalization
Evaluation of the Effect of Local Propolis Application on the Healing of Pressure Ulcers
EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
IDEAL SKIIN CARES Bundle to Prevent Pressure Injury
Body Temperature Changes and Early Postoperatıve Pressure Sore
What is the Incidence of Pressure Ulcer Category II-IV (Including Deep-tissue Injury and Unstageable) on a Static Air Foam Hybrid Mattress?
The Use of a Fully Automated Pulsating Support System (CuroCell® A4 CX20) in Pressure Ulcer Prevention and Treatment
Pressure Ulcer Incidence Cat. II+ on a Static Air Mattress: a Multicenter Cohort Study in Nursing Home Residents at Risk
Safety Evaluation of Sericin-chitosan Cream in Healthy Volunteers
Use of Honey for Pressure Ulcers in Critically Ill Children
Comparison of Static Air Support Devices (Repose®) and Alternating-Pressure Devices in the Prevention of Pressure Ulcers